Woodline Partners’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132M | Buy |
2,467,350
+1,986,614
| +413% | +$106M | 0.7% | 11 |
|
|
2025
Q1 | $19.5M | Buy |
480,736
+100,769
| +27% | +$4.08M | 0.13% | 230 |
|
|
2024
Q4 | $10.6M | Buy |
379,967
+87,499
| +30% | +$2.43M | 0.07% | 329 |
|
|
2024
Q3 | $8.39M | Buy |
292,468
+92,036
| +46% | +$2.64M | 0.07% | 326 |
|
|
2024
Q2 | $4.7M | Buy |
200,432
+71,991
| +56% | +$1.69M | 0.04% | 343 |
|
|
2024
Q1 | $3.24M | Buy |
+128,441
| New | +$3.24M | 0.03% | 397 |
|